Abstract
Neurodegenerative disease has been discovered for more than a hundred years. This disease gradually damages the brain neuron activity and leads to death. There is no way to entirely heal the disease currently but scientists are still looking for some methods to slow it down and heal from it. More hope appears after the third generation of gene editing technology-CRISPR-Cas9- is discovered. This is a natural gene editing technology by CRISPR gene and Cas9 protein in the body with more precision and less cost than the previous two generations. CRISPR-Cas9 technology is based on the natural body system that detects and prevents virus RNA, and targets a precise sequence of genes to accomplish gene editing. Researchers believe that the damage of neurons by the disease could be slowed down or even stopped by knocking out the neurodegeneration related gene and knocking in desired healthy genes. Huntington disease, one of the most popular diseases in neurodegenerative disease, has been discovered relatively more. This research review focuses on the history of CRISPR-Cas9 gene editing technology and how it helps with neurodegenerative disease, especially with Huntington Disease.
Publisher
Darcy & Roy Press Co. Ltd.
Reference14 articles.
1. Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest. 2003 Jan;111(1):3-10. doi: 10.1172/JCI17522. PMID: 12511579; PMCID: PMC151843.
2. Su Y, Li ZQ, Zhou LY, Xu P. International Development Trend of Neurodegenerative Diseases[J]. SCIENCE FOCUS. 2018, 13(3): 1-8 doi:10.15978/j.cnki.1673-5668.201803001
3. Wang XS, Jiang L. [Research advances in the pathogenesis and treatment of neurodegeneration with brain iron accumulation]. Zhongguo Dang Dai Er Ke Za Zhi. 2021 Jun;23(6):650-656. Chinese. doi: 10.7499/j.issn.1008-8830.2103149. PMID: 34130790; PMCID: PMC8213993.
4. Chang Y, Tae-Jin Song. Abstract TMP97: The Burden Of Neurological Diseases In Asia - An Analysis For The Global Burden Of Disease Study 2019. Stroke. 2022 Feb; https://doi.org/10.1161/str.53.suppl_1.TMP97
5. De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A. Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders. International Journal of Molecular Sciences. 2022; 23(15):8714. https://doi.org/10.3390/ijms23158714